Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

LDL-Rezeptor-related-Protein 5

Das LRP5-Gen kodiert einen LDL-Rezeptor, der das gebundene LDL mittels Endozytose internalisiert. Dieser Rezeptor spielt eine wichtige Rolle im Knochen- und Leberstoffwechselsowie im Auge. Mutationen sind für verschiedene Störungen des Knochen-Mineralhaushaltes verantwortlich. Im Auge wird die exudative Vitreoretinopathie Typ 4 ausgelöst und in der Leber können sich multiple Zysten bilden.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Multiplex ligationsabhängige Amplifikation
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Autosomal dominante Osteopetrose 1
LRP5
Polyzystische Lebererkrankung
LRP5
Polyzystische Lebererkrankung 1
PRKCSH
Polyzystische Lebererkrankung 2
SEC63
Osteoporose
CASR
LRP5
RXRA
VDR

Referenzen:

1.

Van Wesenbeeck L et al. (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

external link
2.

Cui Y et al. (2011) Lrp5 functions in bone to regulate bone mass.

external link
3.

Narumi S et al. (2010) Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.

external link
4.

Yadav VK et al. (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.

external link
5.

Qin M et al. (2008) Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy.

external link
6.

Guo YF et al. (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study.

external link
7.

Clément-Lacroix P et al. (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.

external link
8.

Ai M et al. (2005) Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.

external link
9.

Qin M et al. (2005) Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.

external link
10.

Semënov M et al. (2005) SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.

external link
11.

Jiao X et al. (2004) Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5.

external link
12.

Ferrari SL et al. (2004) Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.

external link
13.

Toomes C et al. (2004) Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

external link
14.

Mizuguchi T et al. (2004) LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density.

external link
15.

Kondo H et al. (2003) Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity.

external link
16.

Fujino T et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion.

external link
17.

Magoori K et al. (2003) Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.

external link
18.

None (1995) Familial exudative vitreoretinopathy.

external link
19.

Shastry BS et al. (1997) Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity.

external link
20.

Hey PJ et al. (1998) Cloning of a novel member of the low-density lipoprotein receptor family.

external link
21.

Dong Y et al. (1998) Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity.

external link
22.

de Crecchio G et al. (1998) Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity.

external link
23.

Chen D et al. (1999) Molecular cloning of mouse Lrp7(Lr3) cDNA and chromosomal mapping of orthologous genes in mouse and human.

external link
24.

Mao J et al. (2001) Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway.

external link
25.

Twells RC et al. (2001) The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13.

external link
26.

Gong Y et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

external link
27.

Little RD et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.

external link
28.

Kato M et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.

external link
29.

Boyden LM et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5.

external link
30.

Twells RC et al. (2003) Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene.

external link
31.

Orphanet article

Orphanet ID 123115 external link
32.

NCBI article

NCBI 4041 external link
33.

OMIM.ORG article

Omim 603506 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz